van Burik JA - Search Results

1

Determinants of human immunodeficiency virus DNA and RNA shedding in the anal-rectal canal of homosexual men.

Kiviat NB, Critchlow CW, Hawes SE, Kuypers J, Surawicz C, Goldbaum G, van Burik JA, Lampinen T, Holmes KK. Kiviat NB, et al. Among authors: van burik ja. J Infect Dis. 1998 Mar;177(3):571-8. doi: 10.1086/514239. J Infect Dis. 1998. PMID: 9498434

2

Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation.

Wald A, Leisenring W, van Burik JA, Bowden RA. Wald A, et al. Among authors: van burik ja. J Infect Dis. 1997 Jun;175(6):1459-66. doi: 10.1086/516480. J Infect Dis. 1997. PMID: 9180187

3

Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens.

Liles WC, Huang JE, van Burik JA, Bowden RA, Dale DC. Liles WC, et al. Among authors: van burik ja. J Infect Dis. 1997 Apr;175(4):1012-5. doi: 10.1086/513961. J Infect Dis. 1997. PMID: 9086172

4

Nocardiosis after bone marrow transplantation: a retrospective study.

van Burik JA, Hackman RC, Nadeem SQ, Hiemenz JW, White MH, Flowers ME, Bowden RA. van Burik JA, et al. Clin Infect Dis. 1997 Jun;24(6):1154-60. doi: 10.1086/513654. Clin Infect Dis. 1997. PMID: 9195074

5

Itraconazole therapy for primary cutaneous aspergillosis in patients with AIDS.

van Burik JA, Colven R, Spach DH. van Burik JA, et al. Clin Infect Dis. 1998 Sep;27(3):643-4. doi: 10.1086/517138. Clin Infect Dis. 1998. PMID: 9770169 No abstract available.

6

Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.

Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. Gaviria JM, et al. Among authors: van burik ja. J Infect Dis. 1999 Apr;179(4):1038-41. doi: 10.1086/314679. J Infect Dis. 1999. PMID: 10068606

7

Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo.

Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. Gaviria JM, et al. Among authors: van burik ja. J Infect Dis. 1999 May;179(5):1301-4. doi: 10.1086/314728. J Infect Dis. 1999. PMID: 10191242 Clinical Trial.

8

Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant.

Bowden RA, Cays M, Gooley T, Mamelok RD, van Burik JA. Bowden RA, et al. Among authors: van burik ja. J Infect Dis. 1996 May;173(5):1208-15. doi: 10.1093/infdis/173.5.1208. J Infect Dis. 1996. PMID: 8627074 Clinical Trial.

9

Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation.

Marr KA, White TC, van Burik JA, Bowden RA. Marr KA, et al. Among authors: van burik ja. Clin Infect Dis. 1997 Oct;25(4):908-10. doi: 10.1086/515553. Clin Infect Dis. 1997. PMID: 9356806

10

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients.

Bowden R, Chandrasekar P, White MH, Li X, Pietrelli L, Gurwith M, van Burik JA, Laverdiere M, Safrin S, Wingard JR. Bowden R, et al. Among authors: van burik ja. Clin Infect Dis. 2002 Aug 15;35(4):359-66. doi: 10.1086/341401. Epub 2002 Jul 25. Clin Infect Dis. 2002. PMID: 12145716 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters